Characteristic | UCS (n=17) | EAC (n=34) | p value |
---|---|---|---|
Age, mean (range) | 63.24±2.93 | 54.82±4.49 | <0.001* |
Postmenopausal | Â | Â | 0.001* |
 Yes | 16 | 19 |  |
 No | 1 | 15 |  |
Clinical presentation, no. | Â | Â | 0.325 |
 Abnormal vaginal bleeding | 13 | 28 |  |
 Pelvic pain | 3 | 6 |  |
 Abdominal mass | 1 | 0 |  |
CA125 | Â | Â | 0.579 |
 Elevated | 6 | 8 |  |
 normal | 11 | 26 |  |
Invasion depth | Â | Â | 0.426 |
 ≤1/2 myometrium | 8 | 20 |  |
 > 1/2 myometrium | 9 | 14 |  |
FIGO stage, no. (%) | Â | Â | 0.214 |
 I | 9 | 20 |  |
 II | 2 | 6 |  |
 III | 6 | 8 |  |
 IV | 0 | 0 |  |
lymphatic metastasis |  |  | 0.904 |
 Yes | 3 | 8 |  |
 No | 14 | 26 |  |
LVSI | Â | Â | 0.692 |
 Yes | 8 | 18 |  |
 No | 9 | 16 |  |
UCS subtype, no. (%) | Â | Â | - |
 Homologous | 4(23.53%) | - |  |
 Heterologous | 9(52.94%) | - |  |
 Unspecified | 4(23.53%) | - |  |
EAC classification, no. (%) | Â | Â | - |
 Grade 1 | - | 6(17.65%) |  |
 Grade 2 | - | 10(29.41%) |  |
 Grade 3 | - | 18(52.94%) |  |